BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31138793)

  • 21. CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
    Ruland J; Hartjes L
    Nat Rev Immunol; 2019 Feb; 19(2):118-134. PubMed ID: 30467369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10.
    Hamilton KS; Phong B; Corey C; Cheng J; Gorentla B; Zhong X; Shiva S; Kane LP
    Sci Signal; 2014 Jun; 7(329):ra55. PubMed ID: 24917592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Genetic Heterogeneity of
    Israel L; Mellett M
    Front Immunol; 2018; 9():2239. PubMed ID: 30386326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
    Zhang S; Pan D; Jia XM; Lin X; Zhao X
    Protein Cell; 2017 Nov; 8(11):856-860. PubMed ID: 28717989
    [No Abstract]   [Full Text] [Related]  

  • 25. T cell receptor signals to NF-κB are transmitted by a cytosolic p62-Bcl10-Malt1-IKK signalosome.
    Paul S; Traver MK; Kashyap AK; Washington MA; Latoche JR; Schaefer BC
    Sci Signal; 2014 May; 7(325):ra45. PubMed ID: 24825920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
    Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALT1 protease function in regulatory T cells induces MYC activity to promote mitochondrial function and cellular expansion.
    Rosenbaum M; Schnalzger T; Engleitner T; Weiß C; Mishra R; Mibus C; Mitterer T; Rad R; Ruland J
    Eur J Immunol; 2022 Jan; 52(1):85-95. PubMed ID: 34668583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bcl10 is associated with actin dynamics at the T cell immune synapse.
    Wagh K; Wheatley BA; Traver MK; Hussain I; Schaefer BC; Upadhyaya A
    Cell Immunol; 2020 Oct; 356():104161. PubMed ID: 32768663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
    Nicolau CA; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALT1 substrate cleavage: what is it good for?
    Moud BN; Ober F; O'Neill TJ; Krappmann D
    Front Immunol; 2024; 15():1412347. PubMed ID: 38863711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
    Gewies A; Graß C; Krappmann D
    Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the CBM complex causes T
    Di Pilato M; Kim EY; Cadilha BL; Prüßmann JN; Nasrallah MN; Seruggia D; Usmani SM; Misale S; Zappulli V; Carrizosa E; Mani V; Ligorio M; Warner RD; Medoff BD; Marangoni F; Villani AC; Mempel TR
    Nature; 2019 Jun; 570(7759):112-116. PubMed ID: 31092922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CARD11 signaling in regulatory T cell development and function.
    Carter NM; Pomerantz JL
    Adv Biol Regul; 2022 May; 84():100890. PubMed ID: 35255409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
    Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
    J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
    Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
    Front Immunol; 2019; 10():1898. PubMed ID: 31474984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex.
    Karim ZA; Hensch NR; Qasim H; Alshbool FZ; Khasawneh FT
    Biochem Biophys Res Commun; 2018 Jun; 500(2):268-274. PubMed ID: 29649481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB.
    Paul S; Kashyap AK; Jia W; He YW; Schaefer BC
    Immunity; 2012 Jun; 36(6):947-58. PubMed ID: 22658522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
    Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
    J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function and targeting of MALT1 paracaspase in cancer.
    O'Neill TJ; Tofaute MJ; Krappmann D
    Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.